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Abstract
Background: Almost one-third of all penile metastases are detected at the same time as a primary
tumor, whereas the remaining two-thirds are detected a mean of 18 months after the discovery of
the primary tumor. Cutaneous metastasis of transitional cell carcinoma (TCC) is extremely rare
and generally accepted as the late manifestation of a systemic spread.
Case presentation: We report the first case of simultaneous penile and lung metastases from a
primary TCC of the renal pelvis in a 76-year-old man, that occurred 8 years after a left
nephroureterectomy.
Conclusions: This case report underscores the importance of physical examinations of the skin
of patients who undergo surgical procedures for TCC from bladder as well as from the upper
urinary tract, including those seemingly without metastatic disease, because of the possibility of skin
and penile metastatic spread.
Background
Approximately 300 cases of penile metastases are reported
worldwide [1]. Seventy percent of these metastases have
their origin in the genitourinary tract, and the primary
tumor is most frequently located in the bladder [2]. We
present the first case of penile metastasis from primary
transitional cell carcinoma (TCC) of the renal pelvis, and
discuss the striking feature of discovering lung metastasis
almost simultaneously.
Case presentation
A 76-year-old man with a painful, ulcerative swelling of
the glans that had appeared less than 2 months previously
was brought to our attention. Physical examination
revealed a 3.5-cm fungating lesion involving the upper
half of the glans [Fig. 1]. The lesion was malodorous with
varying amounts of seropurulent discharge, partially
ulcerated, erythematous, and slightly itchy. The superficial
inguinal lymph nodes were not palpable. No similar
lesions were evident on the head, neck, trunk, or arms.
The patient had been treated in another hospital 8 years
previously for TCC of the left renal pelvis by nephroure-
terectomy (pT2 Nx M0 G2). Subsequent postoperative fol-
low-ups (every 6 months for the first 3 years after surgery
and then once every year) consisting of a clinical examina-
tion, total body CT scan, and regular endoscopic
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patient did well until he noticed the painful penile nod-
ule. Pathological examination of incisional biopsies con-
firmed the lesion to be urothelial carcinoma [Fig. 2]. A
subsequent CT workup revealed a 4-cm lesion localized in
the upper-right pulmonary lobe and enlarged pelvic
lymph nodes suggestive of multiple metastases.
The patient began combination chemotherapy (gemcitab-
ine at 1250 mg/m2 on days 1, 8, and 15, and then every
28 days for six courses) and external beam radiotherapy to
the mass, which promptly relieved the penile pain. At an
8-month follow-up the patient was still alive with no
remarkable changes to the pulmonary and lymph node
metastases, or the penile swelling.
Conclusion
Cutaneous metastases from primary TCC of the urinary
system are extremely rare and are generally accepted as
late manifestations of systemic spread [1]. Spector et al.
(1987) suggested that skin metastases in TCC were the
result of increased longevity in successfully treated
patients [3]. Various mechanisms by which lesions may
metastasize to the penis have been reported. Recently Bor-
deau and Lynch and Berger et al. reported three cases of
penile metastases from TCC of the bladder in which they
assumed that metastatic spread from primary bladder can-
cer to the penis occurred mainly via the retrograde venous
route [2,4]. There are also a few reports of TCC seeding
outside the urinary tract after iatrogenic procedures (i.e.,
partial cystectomy, suprapubic cystostomy, pyelotomy,
and laparoscopy) as the cause of cutaneous metastasis
[1,5,6]. Between 5% and 20% of patients with superficial
bladder cancer have vascular or lymphatic spread [5], and
the reported rate of skin metastasis from TCC of the blad-
der is between 0.2% and 2% [7]. The rate of skin metasta-
sis from TCC of the renal pelvis is currently unknown, and
to the best of our knowledge ours is the first reported case
of penile metastasis from TCC of the upper urinary tract.
Almost one-third of all penile metastases are generally
detected at the same time as a primary tumor, whereas the
remaining two-thirds are detected a mean of 18 months
after the discovery of the primary tumor [8]. Because the
disease-free survival of this patient was 8 years following
the diagnosis of the primary tumor, this case report repre-
sents a description of the biology of an unusual tumor.
Moreover, the penile metastasis in this case was not the
late manifestation of systemic spread, as is usually
reported in the literature [1]; in fact, the patient was accu-
rately evaluated with a standard follow-up scheme. There-
fore, it is plausible that the lung metastasis appears almost
simultaneously with the penile metastasis.
The optimal treatment of penile metastasis requires a
multidisciplinary approach that is correlated with the dis-
ease extent. The average survival in patients with penile
metastasis is 3.9 months from diagnosis and, with exten-
sive surgery and chemotherapy, a survival of 9.2 months
has been reported [4].
This patient was not eligible for platinum-based regimens
due to impaired renal function (prior nephrectomy) and
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advanced age. As a result, he was treated with gemcitabine
as a single agent. This treatment has demonstrated objec-
tive response rates of 25–29% with minimal toxicity as
compared to standard regimens [9-11].
In conclusion, this case report suggests that particular
attention should be paid to physical examination of the
skin of patients who undergo surgical procedures for TCC
from bladder as well as from the upper urinary tract,
including those seemingly without metastatic disease,
because of the possibility of skin and penile metastatic
spread.
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